0001209191-20-007326.txt : 20200206
0001209191-20-007326.hdr.sgml : 20200206
20200206200403
ACCESSION NUMBER: 0001209191-20-007326
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200204
FILED AS OF DATE: 20200206
DATE AS OF CHANGE: 20200206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHEN JIN-LONG
CENTRAL INDEX KEY: 0001642996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38853
FILM NUMBER: 20584280
MAIL ADDRESS:
STREET 1: 630 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001426332
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-243-5555
MAIL ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-04
0
0001426332
NGM BIOPHARMACEUTICALS INC
NGM
0001642996
CHEN JIN-LONG
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
16.47
2020-02-04
4
A
0
175000
0.00
A
2030-02-03
Common Stock
175000
175000
D
The shares subject to the stock option vest over a four-year period commencing January 1, 2020, with 1/48th of the shares vesting on a monthly basis.
/s/ Jin Long-Chen
2020-02-06